Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
CABAZITAXEL
CABAZITAXEL
departments:
肿瘤科
drug:
注射液
Active:
CABAZITAXEL
indication:
转移性前列腺癌
Licensor:
Sandoz, Inc.
Approved Country/Region:
美国
Approval time:
2023-10-27